Skinvisible (OTCMKTS:SKVI) Releases Earnings Results

Skinvisible (OTCMKTS:SKVIGet Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.05) EPS for the quarter, Zacks reports.

Skinvisible Price Performance

SKVI stock remained flat at $0.24 during mid-day trading on Wednesday. 1,000 shares of the company’s stock traded hands, compared to its average volume of 70. The stock’s 50 day moving average is $0.34 and its two-hundred day moving average is $0.35. The stock has a market capitalization of $1.28 million, a price-to-earnings ratio of -3.39 and a beta of 1.53. Skinvisible has a 52-week low of $0.08 and a 52-week high of $0.90.

Skinvisible Company Profile

(Get Free Report)

Skinvisible, Inc, together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company's flagship product is Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products.

See Also

Earnings History for Skinvisible (OTCMKTS:SKVI)

Receive News & Ratings for Skinvisible Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skinvisible and related companies with MarketBeat.com's FREE daily email newsletter.